Altered Polarization and Impaired Phagocytic Activity of Lung Macrophages in People With Human Immunodeficiency Virus and Chronic Obstructive Pulmonary Disease

© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissionsoup.com..

BACKGROUND: People with human immunodeficiency virus (PWH) have an increased risk of developing chronic obstructive pulmonary disease (COPD).

METHODS: We phenotyped lung macrophages in 4 subgroups-M1 (CD40+CD163-), M2 (CD40-CD163+), double positives (CD40+CD163+), and double negatives and (CD40-CD163-)-and we determined their phagocytic capacity in PWH with and without COPD.

RESULTS: People with human immunodeficiency virus with COPD have more double-negative macrophages (84.1%) versus PWH without (54.3%) versus controls (23.9%) (P=.004) and reduced phagocytosis (P=.012). Double-negative macrophages had the worst phagocytic capacity (P<.001).

CONCLUSIONS: People with human immunodeficiency virus with COPD have an abundance of nonpolarized macrophages, which have poor phagocytic capacity and therefore predispose PWH to increased risk of disease progression.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:225

Enthalten in:

The Journal of infectious diseases - 225(2022), 5 vom: 02. März, Seite 862-867

Sprache:

Englisch

Beteiligte Personen:

Akata, Kentaro [VerfasserIn]
Leung, Janice M [VerfasserIn]
Yamasaki, Kei [VerfasserIn]
Leitao Filho, Fernando S [VerfasserIn]
Yang, Julia [VerfasserIn]
Xi Yang, Chen [VerfasserIn]
Takiguchi, Hiroto [VerfasserIn]
Shaipanich, Tawimas [VerfasserIn]
Sahin, Basak [VerfasserIn]
Whalen, Beth A [VerfasserIn]
Yang, Cheng Wei Tony [VerfasserIn]
Sin, Don D [VerfasserIn]
van Eeden, Stephan F [VerfasserIn]

Links:

Volltext

Themen:

COPD
Journal Article
Lung macrophages
PWH
Phagocytosis
Phenotype
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 09.05.2022

Date Revised 09.05.2022

published: Print

ClinicalTrials.gov: NCT02833480

Citation Status MEDLINE

doi:

10.1093/infdis/jiab506

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM331513315